Generic antihypertensive medications with therapeutic interchangeability requirements
Señor Editor: La hipertensión arterial (HTA) es el factor de riesgo cardiovascular más prevalente y causa de muerte prematura a nivel mundial. Según Organización Mundial de la Salud (OMS) la HTA provoca 7,5 millones de muertes al año, que equivale al 13% del total de defunciones que se producen a...
Main Authors: | Giulianna Gamero-Vega, Percy Ocampo-Rujel |
---|---|
Format: | Article |
Language: | English |
Published: |
Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA)
2019-11-01
|
Series: | Journal of Pharmacy & Pharmacognosy Research |
Subjects: | |
Online Access: | http://jppres.com/jppres/pdf/vol7/jppres19.599_7.6.408.pdf |
Similar Items
-
New Anticonvulsants: Interchangeability Issues and the Use of Generic Anticonvulsants in Clinical Practice
by: V. V. Arkhipov, et al.
Published: (2019-06-01) -
Interchangeability of Fluconazole Drugs
by: N. D. Bunyatyan, et al.
Published: (2018-12-01) -
Therapeutic Interchange of Parenteral Anticoagulants: Challenges for Pharmacy and Therapeutics Committees
by: Alpesh Amin
Published: (2011-11-01) -
Actual questions of clinical pharmacology by amlodipine: should we prefer the original or a generic drug?
by: A. S Dukhanin
Published: (2016-12-01) -
Interchangeability of Essential Phospholipid Products
by: N. D. Bunyatyan, et al.
Published: (2019-12-01)